BIOTON S.A. (WSE:BIO)
3.950
0.00 (0.00%)
Feb 10, 2026, 5:00 PM CET
BIOTON Revenue
BIOTON had revenue of 72.65M PLN in the quarter ending September 30, 2025, with 73.06% growth. This brings the company's revenue in the last twelve months to 295.81M, up 66.56% year-over-year. In the year 2024, BIOTON had annual revenue of 207.76M with 14.38% growth.
Revenue (ttm)
295.81M
Revenue Growth
+66.56%
P/S Ratio
1.15
Revenue / Employee
814.91K
Employees
364
Market Cap
339.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 207.76M | 26.13M | 14.38% |
| Dec 31, 2023 | 181.64M | -51.52M | -22.10% |
| Dec 31, 2022 | 233.16M | 70.13M | 43.01% |
| Dec 31, 2021 | 163.03M | -58.75M | -26.49% |
| Dec 31, 2020 | 221.79M | 19.76M | 9.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ryvu Therapeutics | 90.41M |
| Synthaverse | 71.76M |
| Mabion | 14.81M |
| Captor Therapeutics Spolka Akcyjna | 7.57M |
| Molecure | 5.86M |
| Urteste | 1.80M |
| Pharmena | 1.27M |
| Poltreg | 250.00K |